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An exploratory study of 
predisposing genetic factors 
for DiGeorge/velocardiofacial 
syndrome
Laia Vergés1, Francesca Vidal1, Esther Geán2, Alexandra Alemany-Schmidt3, Maria Oliver-Bonet3 & 
Joan Blanco1
DiGeorge/velocardiofacial syndrome (DGS/VCFS) is a disorder caused by a 22q11.2 deletion mediated 
by non-allelic homologous recombination (NAHR) between low-copy repeats (LCRs). We have evaluated 
the role of LCR22 genomic architecture and PRDM9 variants as DGS/VCFS predisposing factors. We 
applied FISH using fosmid probes on chromatin fibers to analyze the number of tandem repeat blocks 
in LCR22 in two DGS/VCFS fathers-of-origin with proven 22q11.2 NAHR susceptibility. Results revealed 
copy number variations (CNVs) of L9 and K3 fosmids in these individuals compared to controls. The total 
number of L9 and K3 copies was also characterized using droplet digital PCR (ddPCR). Although we were 
unable to confirm variations, we detected an additional L9 amplicon corresponding to a pseudogene. 
Moreover, none of the eight DGS/VCFS parents-of-origin was heterozygote for the inv(22)(q11.2) 
haplotype. PRDM9 sequencing showed equivalent allelic distributions between DGS/VCFS parents-of-
origin and controls, although a new PRDM9 allele (L50) was identified in one case. Our results support 
the hypothesis that LCR22s variations influences 22q11.2 NAHR events, however further studies are 
needed to confirm this association and clarify the contribution of pseudogenes and rare PDRM9 alleles 
to NAHR susceptibility.
The human genome is constituted by 5% of segmental duplications (SDs) or low-copy repeats (LCRs). They are 
defined as near-identical DNA segments (> 90% sequence identity), longer than 1 kb and repeated in tandem or 
interspersed throughout the genome1. LCRs contain genes, pseudogenes, repetitive elements and recombination 
motifs2,3, which render LCRs unstable and make them prone to misalignments that can lead to non-allelic homol-
ogous recombination (NAHR). NAHR events occurring during meiosis result in chromosome reorganizations 
that can be transmitted to the offspring4–6. This process played an important role during primate evolution, which 
has been deduced from the significant SD expansion in the human genome7. NAHR events mediated by LCRs are 
also responsible for the copy number variations (CNVs) that introduce genetic diversity between individuals8. 
However, some CNVs also originate a group of diseases that have been referred as genomic disorders9.
NAHR activity during meiosis can be evaluated in gametes by estimating the rearrangement frequency at a 
specific locus with polymerase chain reaction (PCR)10 or fluorescence in situ hybridization (FISH)11. Sperm-FISH 
studies in Prader-Willi syndrome (PWS) and DiGeorge/velocardiofacial syndrome (DGS/VCFS) fathers-of-origin 
have demonstrated that there are individuals with an increased susceptibility to deletions12,13. The recurrence 
risk for PWS and DGS/VCFS in these individuals is considered higher than the general population due to their 
increased susceptibility to NAHR events during spermatogenesis.
NAHR susceptibility in parents-of-origin has been related to different genetic features. CNVs in the LCRs 
flanking the critical regions have been described as predisposing factors for Smith-Magenis and Potocki-Lupski 
syndrome14,15, Williams-Beuren syndrome16 and 16p12.1 microdeletion disease17. Inversions of the criti-
cal region have been related to the occurrence of Prader-Willi/Angelman syndromes18,19, Williams-Beuren 
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syndrome20–22, Smith-Magenis syndrome23, 17q21.31 microdeletions24 and t(8;22)25, among other genomic 
disorders26. According to these observations, genomic architecture variations in parents-of-origin may confer 
a higher likelihood of LCR misalignment during meiosis and consequently a higher susceptibility to NAHR 
events. Moreover, variants of recombination genes have also been associated with altered frequency and stability 
of meiotic recombination that might also predispose to NAHR27,28. The PRDM9 protein regulates the pattern of 
meiotic recombination in the mammal genome by recruiting the double-strand break machinery after recogniz-
ing consensus sequences constituted by zinc finger domains29,30. Nucleotide changes in zinc finger domain shift 
the binding motif and modify the hot-spot pattern31. Therefore, the PRDM9 genotype determines the likelihood 
of a NAHR event in a critical region. In this context, some PRDM9 alleles have been suggested to increase the 
risk for transmitting Charcot-Marie-Tooth type 1 A, hereditary neuropathy with liability to pressure palsies and 
Williams-Beuren syndrome, among other genomic disorders28,32,33.
The DiGeorge/velocardiofacial syndrome (DGS/VCFS) (OMIM 188400/OMIM 192430) is the most common 
deletion syndrome in humans, with an incidence of 1:4000 newborns34. The genetic cause is gene haploinsufficiency 
resulting from a microdeletion of the 22q11.2 region. Roughly 11% of this region is comprised by eight highly 
homologous LCRs (LCR22-2, LCR22-3a, LCR22-3b, LCR22-4, LCR22-5, LCR22-6, LCR22-7 and LCR22-8)35. 
LCR22s act as substrate for the pathogenic rearrangements that originate DGS/VCFS, as well as a variety of other 
genomic disorders36. Focusing on DGS/VCFS rearrangements, they involve LCR22-2 and LCR22-4 in more than 
85% of cases, giving rise to a 3 Mb deletion37. NAHR between LCR22-2 and LCR22-3a originates a 1.5 Mb dele-
tion which affects 7% of cases. Distal LCR22s are involved in the remaining DGS/VCFS unusual deletions38–40 
(Fig. 1A).
Little is known about the variability of the 22q11.2 genomic architecture and its influence in NAHR suscep-
tibility41. Some authors have hypothesized about a possible relationship between the frequency of 22q11.2 rear-
rangements and variations in LCR22s13,42,43. On the other hand, although in other genomic disorders the presence 
of heterozygote inversions has been associated with an increased frequency of rearrangements, no inv(22)(q11.2) 
have been described in DGS/VCFS parents44,45. The influence of the PRDM9 genotype in the DGS/VCFS trans-
mission risk has also been discussed; nevertheless, an association of PRDM9 allele and NAHR susceptibility has 
not been clearly established32,46.
In this work, we assessed if the risk of DGS/VCFS is influenced by the genomic architecture of LCR22s, the 
presence of 22q11.2 inversions and the PRDM9 genotype. First, we analysed CNVs of tandem sequence blocks 
within LCR22-2 and LCR22-4 and CNVs of paralogous sequences interspersed throughout LCR22s using FISH 
on extended chromatin fibers (fiber-FISH) and droplet digital PCR (ddPCR), respectively. Second, we devel-
oped an interphase FISH assay to genotype inversions between LCR22-2 and LCR22-4. Finally, we analysed the 
PRDM9 genotype by sequencing the zinc finger array.
Results
LCR22-2 and LCR22-4 tandem sequence blocks. The LCR22-2 and LCR22-4 genomic architecture was 
analysed in lymphocyte stretched chromatin fibers using fosmid and single-copy BAC clones (Human genome 
February 2009 assembly; UCSC Genome Browser; http://genome.ucsc.edu/) (Fig. 1B). Single copy BAC clones 
were selected to delimit the proximal and distal ends of LCR22-2 (RP11-66F9 (abbr. F9) and RP11-163A10 (abbr. 
A10)) and LCR22-4 (RP11-505B16 (abbr. B16) and RP11-47L18 (abbr. L18)). The experimental design also 
required the use of fosmid clones covering the length of LCR22-2 (WI2-938L9 (abbr. L9), WI2-451K3 (abbr. 
K3), WI2-1268B22 (abbr. B22) and WI2-1822L21 (abbr. L21)) and LCR22-4 (WI2-938L9 (abbr. L9), WI2-451K3 
(abbr. K3), WI2-1268B22 (abbr. B22), WI2-2886M12 (abbr. M12) and WI2-3344I18 (abbr. I18)) (Fig. 1B and 
Supplementary Table S1).
Normal ranges of tandem sequence blocks were established by taking the smallest and the largest CNVs 
observed within six control individuals. For LCR22-2, normal ranges were 2–6 copies for L9, 3–9 copies for K3, 
1–4 copies for B22 and 1–2 copies for L21; for LCR22-4 were 1–2 copies for L9, 1–3 copies for K3, 1–2 copies for 
B22, 2–2 copies for M12 and 2–3 copies for I18 (Table 1; Fig. 2). Two DGS/VCFS fathers-of-origin with a previ-
ously proven 22q11.2 NAHR susceptibility were also examined13. Both fathers showed out of range numbers of 
fosmid blocks. DG2F presented two copies of K3 blocks in both LCR22-2 haplotypes rather than the 3–9 copies 
in the controls, and three copies of L9 blocks in one LCR22-4 haplotype rather than the 1–2 copies in controls. 
Otherwise, DG5F presented eight copies of L9 blocks in both haplotypes from LCR22-2 rather than the 2–6 
copies in the controls, and three copies of L9 blocks in one haplotype from LCR22-4 rather than the 1-2 copies in 
controls (Table 1; Fig. 2).
LCR22 paralogous sequences. To validate the fiber-FISH results, the total number of L9 and K3 blocks 
scattered around LCR22s was analysed by ddPCR using lymphocyte genomic DNA. This was done in those 
samples previously analysed by fiber-FISH (C1, C2, C3, C4, C5, C6, DG2F and DG5F). The L9 and K3 ddPCR 
results did not correlate with fiber-FISH (Spearman correlation test, r = 0.156 and 0.386, P = 0.703 and 0.360, 
respectively).
Next, we determined the normal range of L9 and K3 copies in 21 and 6 control samples respectively. The L9 
range extends from 12.7 to 29.6 (Fig. 3A), while K3 extends from 10.6 to 21 (Fig. 3C). The mean L9 copy number 
in controls and in the eight DGS/VCFS parents-of-origin was 19.54 and 21.28 respectively, while the mean K3 
copy number was 15.33 in controls and 17.46 in DGS/VCFS parents-of-origin. However, L9 and K3 copies failed 
to reach significant differences between both groups (Mann Whitney test, P = 0.420 and 0.477, respectively). At 
the individual level, only DG1F obtained a K3 copy number above the normal range observed in controls (22 
copies) (Fig. 3A).
Interestingly, we detected two types of amplicons for L9 fosmid which were differentiated by the fluores-
cence amplitude (Fig. 3B). It has been described that droplets with lower fluorescence amplitude are amplicons of 
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different size that may correspond to pseudogene sequences47. 66.67% of control individuals (14 of 21) presented 
two or more copies per genome of the L9 pseudogene, while in DGS/VCFS parents-of-origin this figure reached 
only 37.50% (3 of 8) (Fig. 3A). However, these differences did not reach statistical significance (Fisher exact test, 
P = 0.218).
22q11.2 inversions. 22q11.2 inversions were evaluated in five control individuals and eight parents-of- 
origin. We performed an assay using a combination of three BAC clones including RP11-66F9 (abbr. F9) covering 
the proximal end of the LCR22-2 and RP11-505B16 (abbr. B16) and RP11-47L18 (abbr. L18) covering the proxi-
mal and the distal end of the LCR22-4, respectively (Fig. 1C and Supplementary Table S1).
Figure 1. Experimental approach to assess the genomic architecture of DGS/VCFS critical region.  
(A) Schematic representation of the DGS/VCFS critical region. Main deletions mapped are in broken lines.  
(B) BAC and fosmid probe combinations for the study of LCR22-2 and LCR22-4 using fiber-FISH. The three  
co-hybridized probes are unequivocally labelled to visualize the copy number variations of each fosmid 
sequence in a single LCR: proximal BAC (red and green), fosmid (green) and distal BAC (red). (C) BAC probes 
to study 3 Mb inversions between LCR22-2 and LCR22-4. Normal haplotypes (N) present clustered RP11-
505B16 and RP11-47L18 signals (green and red) and a separated RP11-66F9 signal (blue). 3 Mb inversion 
haplotypes (inv) present clustered RP11-66F9 and RP11-505B16 signals (blue and green) and a separated RP11-
47L18 signal (red). (D) Block copy number of WI2-451K3 in LCR22-2 (left) and in LCR22-4 (right) observed 
by fiber-FISH. (E) Normal (N) and inverted (inv) haplotypes ascertained by interphase FISH in lymphocyte 
nuclei. Example of three normal (N) and one inverted haplotype (inv) in two lymphocyte nuclei.
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A total of 1354 informative signal combinations, 512 from control individuals and 842 from DGS/VCFS 
parents-of-origin, were analysed (Supplementary Table S2). The mean frequency of normal haplotypes was 
96.08% in control individuals (range 94.12% to 98.06%) and 96.92% in DGS/VCFS parents-of-origin (range 
94.55% to 99.02%). The mean frequency of the 3 Mb inversion haplotype was 1.57% in control individuals (range 
0.96% to 2.94%) and 1.56% in DGS/VCFS parents-of-origin (range 0% to 2.91%). We also detected a negligible 
percentage of informative haplotypes with an unexpected probe association attributed to inherent hybridization 
errors (Supplementary Table S2).
The frequency of 3 Mb inversions was statistically significant lower than the frequency expected in a hete-
rozygous situation in all the cases (Chi square-test, P < 0.05) (Table 2 and Supplementary Table S2). Haplotype 
frequencies were not different between both populations (Mann Whitney test, P > 0.05).
PRDM9 genotype. Sequencing of the PRDM9 zinc finger array was performed in 19 control individuals and 
eight DGS/VCFS parents-of-origin. We observed the common A allele, constituted by 13 zinc finger repeats (ZF), 
in 86.84% of our control population and in 81.25% of the case population. One new allele showing more than 13 
ZF was identified (L50); unfortunately, we were unable to define its ZF combination due to technical limitations 
(Fig. 4 and Supplementary Table S3).
Control and case allele frequencies did not show differences (Fisher’s exact test, P > 0.05). DGS/VCFS fathers 
showing an increased NAHR susceptibility at 22q11.2 (DG2F and DG5F) presented the A/L50 and A/A geno-
types, respectively.
Discussion
The recurrence risk for transmitting genomic disorders is generally considered not higher than that for the 
normal population. However, some insights have been provided into the predisposing genetic factors for these 
Sample ID
LCR22.2 LCR22.4
K3 L9 B22 L21 K3 L9 B22 M12 I18
Controls
C1 5\7 5\6 2\3 1\2 2\3 2\2 1\2 2\2 2\2
C2 7\9 5\10* 3\5* 1\2 2\2 2\2 1\2 2\2 2\3
C3 3\5 3\5 1\2 1\2 1\2 1\2 1\1 2\2 2\2
C4 3\5 3\5 2\3 1\1 2\2 2\2 1\1 2\2 2\2
C5 3\3 2\5 2\4 1\2 1\2 1\2 2\2 2\2 2\2
C6 3\5 2\4 1\2 1\1 1\2 2\2 1\2 2\2 2\2
Normal range** 3–9 2–6 1–4 1–2 1–3 1–2 1–2 2–2 2–3
DGS/VCFS fathers***
DG2F 2\2 3\6 2\3 1\2 2\2 2\3 1\2 2\2 2\2
DG5F 5\8 8\8 2\3 1\2 2\2 2\3 1\2 2\2 2\2
Table 1.  CNVs of tandem sequence blocks. *Outlier. **Ranges established with the lowest and the highest 
values in control individuals excluding outliers. ***DGS/VCFS fathers-of-origin with increased number of 
22q11.2 sperm deletions (Vergés et al.13). The two haplotypes for each individual are separated by a backslash. 
Bold numbers indicate CNVs out of the normal range.
Figure 2. Fiber-FISH analysis of tandem sequence blocks of LCR22-2 and LCR22-4. The floating bar graph 
represents CNVs of tandem sequence blocks in control individuals. Boxes mark the minimum and maximum 
values while dashed lines represent the mean. Data from DGS/VCFS fathers-of-origin with increased NAHR 
susceptibility at 22q11.2 (DG2F and DG5F) are superimposed over the graphic.
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diseases. Our exploratory analyses reveal that the LCR22 genomic architecture, through CNVs of the segmental 
duplication blocks, could be a predisposing factor for transmitting DGS/VCFS.
Figure 3. Quantification of copies of LCR22s paralogous sequences by ddPCR in control individuals and 
DGS/VCFS parents-of-origin. (A) Mean L9 sequences (grey bars) and L9 pseudogene sequences (black bars) 
per haplotype. Dashed lines represent the limits of the normal range observed in controls (C1–C21). (B) ddPCR 
results showing different types of amplicons for L9 fosmid sequence. DG2F shows a single group of positive 
droplets, while DG5F shows a second group of positive droplets with lower fluorescence amplitude. (C) Mean K3 
sequences per haplotype. Dashed lines represent the limits of the normal range observed in controls (C1–C6).
Sample ID Relationship








genotype22q11.21 15q11-q132 7q11.22 LCR22-2 LCR22-4
DG1F DGS/VCFS father Normal Normal Normal — — 5 Absence A/A
DG2F DGS/VCFS father Increased Normal Normal Decreased Increased 0 Absence A/L50
DG3F DGS/VCFS father Normal Normal Normal — — 0 Absence A/L9
DG5F DGS/VCFS father Increased Normal Normal Increased Increased 3 Absence A/A
DG6M DGS/VCFS mother — — — — — 2 Absence A/A
DG7F DGS/VCFS father Normal Normal Normal — — 0 Absence A/A
DG8F DGS/VCFS father Normal Normal Normal — — 0 Absence A/L24
DG9M DGS/VCFS mother — — — — — 0 Absence A/A
Table 2.  Genetic features assessed in DGS/VCFS parents-of-origin. 1Data extracted from Vergés et al.13. 
2Unpublished data.
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LCR sequences present a poor precision within databases, which complicates the knowledge of their struc-
tural variation. Their repetitive nature constitutes an important impediment for accurate sequencing procedures. 
Nonetheless, different approaches, such as massively parallel sequencing techniques, PCR or FISH, have been 
applied to analyse repetitive regions16,48–51. Fiber-FISH provides a direct analysis of genome architecture with high 
resolution, i.e. 10–20 kb52. Moreover, the visualization of repeating patterns allows for identifying heterozygote 
haplotypes and analyzing LCRs individually. For these reasons, fiber-FISH is the preferred method for studies of 
the genomic structure of complex CNVs53. However, it cannot differentiate tandem copies of the regions recog-
nized by the fosmids. Accordingly, we had to consider that, in the visualization of repeated patterns, each signal 
corresponds to a block of tandem sequences of each fosmid (Fig. 1C). Despite overtaking the identification of 
tandem sequences and detecting pseudogene sequences, PCR-based methods cannot differentiate heterozygote 
haplotypes or analyse variations at the LCR level.
CNVs within LCRs have been previously reported in a database of genomic variants, thus demonstrating their 
polymorphic length54. Our ddPCR results reinforce this interpretation since the data show the inter-individual 
variability of LCR22 repeated sequences. Moreover, the fiber-FISH results show that LCR22-2 inter-individual 
variability was higher than that of LCR22-4. Focusing on those fosmid clones analysed in both LCRs (L9, K3 and 
B22), LCR22-2 showed larger ranges of tandem sequence blocks per fosmid, especially from those blocks cor-
responding to tandem sequences of L9 and K3. On the contrary, LCR22-4 showed less variable numbers for the 
five fosmids analysed with restricted ranges of copies and minor differences between individuals (Fig. 3, Table 1). 
These observations suggest that LCR22-2 is longer than LCR22-4. Indeed, LCR22-2 mediates the majority of rear-
rangements affecting the 22q11.2 region and is the LCR22 with the highest rates of allelic homologous recombi-
nation (AHR)43. Probably a longer LCR22 might contain more recombination motifs, which what would explain 
its higher AHR and also the increased likelihood of misalignments and NAHR events. Concordantly, LCR length, 
homology degree of segmental duplication blocks and the density of recombination motifs have been related to 
the NAHR frequency of recurrent rearrangements3.
In DGS/VCFS fathers-of-origin, we identified abnormal CNVs of the tandem sequence blocks for L9 and K3 
fosmids. We previously demonstrated that these individuals showed significant increases of sperm 22q11.2 dele-
tions13. In both cases, the deletion in the affected children correspond to the 3 Mb segment between LCR22-2 and 
LCR22-413. Furthermore, parallel investigations in the same individuals determined the rearrangement frequency 
at other critical regions with a similar genomic architecture by applying sperm FISH experiments based on the 
methodology described by Molina et al.11. These studies demonstrated that NAHR susceptibility was restricted 
at the DGS/VCFS critical region because they presented normal deletion and duplication sperm rates for the 
Williams-Beuren syndrome and the Prader-Willi syndrome regions (7q11.23 and 15q11-q13) (Table 2; unpub-
lished data). Altogether, our results support the association between increased rates of rearrangements during 
spermatogenesis and specific genetic features of the critical region and reject a generalized instability origin for 
these abnormal deletion rates.
CNVs within LCRs affect the number of different types of sequences such as genes, pseudogenes and recom-
bination motifs. The L9 and K3 sequences (UCSC Genome Browser) encompass partial or complete genes and 
pseudogenes; L9 covers USP18 and AK129567, whereas K3 covers AK302545 and GGT3P. The density of PRDM9 
A binding motifs (CCNCCNTNNCCNC) is three on L9 and two on K3. It is important to remark that the gene 
AK129567 covered by L9 sequence belongs to the common breakpoint region of the 22q11.2 deletion55. The most 
frequent breakpoints at LCR22-2 and LCR22-4 occur in regions including DGCR6, PRODH and AK129567 at 
the proximal end and GGT2, HIC2, RIMBP3 and AK129567 at the distal end55. These regions are also covered 
by the fosmid sequences L21 and M12 which, despite presenting a low variation in our analyses, contain higher 
sequences of recombination motifs (eight and 14, respectively) (Supplementary Table S4). It has been demon-
strated that the PRDM9 recombination motif density at LCRs has a positive correlation with the NAHR fre-
quency. Specifically, structural variants generated by NAHR present breakpoints enriched with PRDM9 defined 
hotspots3,28,29. Hence, the concentration of PRDM9 recombination motifs may define the location of the rear-
rangement breakpoints, whereas the misalignment probability could be driven by variations in the degree of 
homology between paralogous sequences. L9 and K3 CNVs might produce variations in the degree of homology 
between LCR22-2 and LCR22-4, leading to non-allelic alignments of the susceptible breakpoint regions during 
Figure 4. Distribution of PRDM9 alleles in control individuals and DGS/VCFS parents-of-origin. 
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meiotic prophase I that would be solved in NAHR events. Instead, the DSB formation to start a NAHR event 
might be driven by adjacent sequences with a high recombination motif density, such as L21 or M12 sequences.
Different authors have reported a correlation between the alignment length and the sequence identity between 
paired LCRs and NAHR frequency3,56, thus supporting the idea that CNVs at LCRs might change NAHR suscep-
tibility. Moreover, according to the ectopic synapsis model15, variations in the length of the LCRs might originate 
ectopic presynaptic contacts between near homologous segments that would act as a precursor to NAHR.
Regarding the total number of paralogous LCR22s sequences, the ample spectrum of CNVs detected endorse 
the polymorphic variation of these sequences and the uncertainty of the human reference assemblies in LCR 
regions. Comparing the control and DGS/VCFS parent-of-origin populations, we did not find any relationship 
between the CNVs of paralogous sequences and the risk for transmitting DGS/VCFS. At the individual level, 
we observed one DGS/VCFS father-of-origin with a CNV of K3 sequences out of the control range. However, 
considering that this father did not show NAHR susceptibility in previous studies13 and that, due to the technical 
characteristics of ddPCR, we could not attribute the higher copy number to a specific LCR22, we believe that this 
outcome is not relevant for the evaluation of the transmitting risk of this subject. Analyses of CNVs in multiple 
LCRs using ddPCR concealed variations in specific LCRs detected by fiber-FISH. This situation explains the lack 
of concordance between the data provided by both techniques and reinforces the need to analyse the LCR archi-
tecture with LCR-specific methods.
Although the CNVs of pseudogene sequences were not conclusive due the limited sample size, we do believe 
that the presence of such sequences could be another variable to take into account. Genetic variations in pseu-
dogene sequences located at LCRs have been already proposed as rearrangement promoters57. We observed 
that, in DGS/VCFS parents-of-origin, the presence of a possible AK129567 pseudogene sequence was less fre-
quent than in the general population. The absence of pseudogene sequences might alter the degree of homol-
ogy between LCR22-2 and LCR22-4, enhancing their misalignment, which would cause more NAHR events. 
Nevertheless, as we have just described, the ddPCR technique hampers the assignation of these CNVs to any 
LCR22. Consequently, we are aware that these pseudogene sequence variations might be located in a LCR that is 
not involved in the DGS/VCFS reorganization.
Parental inversion polymorphisms have also been proposed as a susceptibility factor for NAHR events in mul-
tiple genomic disorders, especially in Williams-Beuren syndrome20–22. With regard to the 22q11.2 inversions, in 
agreement with the work of Gebhardt et al.44 and Saitta et al.45, we did not observe any haplotype corresponding 
to the 3 Mb inversion, either in DGS/VCFS parents-of-origin or in control individuals. These results discard the 
presence of heterozygous inversions as a predisposing factor for 22q11.2 deletions.
Concerning the role of the PRDM9 genotype, we did not find differences between the allelic frequencies of 
controls and DGS/VCFS parent-of-origin populations. Despite the limited sample size, and considering that 
other authors also failed to identify this association32,46, the results indicate that there are non-specific PRDM9 
alleles related to DGS/VCFS susceptibility. Accordingly, our data support the idea that the PRDM9 genotype has 
a limited influence on NAHR events. Indeed, although the PRDM9 A allele has been proposed as a predisposing 
factor for CMT1A or HNPP33, this allele is extremely common in Caucasians, suggesting that this genetic feature 
cannot be a predisposing factor by itself33. However, it is interesting to note that the finding of a minor and unde-
scribed allele in DG2F might indicate a possible influence as a NAHR catalyst in this individual. Actually, rare 
PRDM9 alleles might contribute to different hotspot patterns that create unusual DSBs at disease-causing 22q11.2 
deletion breakpoints.
The risk of transmitting a genomic disorder is a complex trait that could be attributed to a confluence of dif-
ferent genetic characteristics. First, regarding the 22q11.2 genomic architecture, we have raised the possibility 
that CNVs of segmental duplication blocks within LCR22-2 and LCR22-4 could be considered as a DGS/VCFS 
predisposing factor. Moreover, our results also suggest a possible implication of pseudogene sequence CNVs. 
Second, although the PRDM9 genotype does not seem to be a decisive predisposing factor, we cannot reject its 
contribution in the definition of the DGS/VCFS transmitting risk due to the possible existence of rare PRDM9 
alleles capable of creating new hot spot patterns. The PRDM9 genotype and the LCR22 genomic architecture 
could have a synergistic effect considering that CNVs at LCR22s also vary the number and distribution of recom-
bination motifs.
Our results provided a comprehensive approximation to the analysis of DGS/VCFS predisposing genetic fac-
tors in parents-of origin. Although designed as an exploratory study, results suggested that CNVs in LCR22s 
predispose to sperm 22q11.2 deletions. Nevertheless, further studies is a larger cohort of individuals are needed 
to confirm the contribution of segmental duplication blocks, and better understand the participation of pseu-
dogenes and rare PDRM9 alleles to NAHR 22q11.2 susceptibility.
Methods
Study population. This study was carried out on six DGS/VCFS fathers-of-origin, two DGS/VCFS moth-
ers-of-origin and a total of 26 control individuals (Fig. 5). To our knowledge, none of them had been exposed to 
genotoxic agents, and no history of chemotherapy, radiotherapy or chronic illness was recorded. In DGS/VCFS 
families, the parental origin of the deleted chromosome, and the frequency of sperm 22q11.2 deletions, were 
previously reported13.
All the individuals gave their informed consent in writing to participate in the study and the protocols were 
approved by the Ethics Commission on Human and Animal Experimentation of the Universitat Autònoma 
de Barcelona. All experiments were conducted in accordance with the informed consent and the approved 
guidelines.
Biological samples. Peripheral blood samples were collected in EDTA-containing tubes (5 ml). Genomic 
DNA was isolated using the Gentra Puregene Blood kit (QUIAGEN Inc.) following the manufacturer’s 
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instructions. Peripheral blood samples were also collected in 1% sodium heparin tubes in eight DGS/VCFS 
parents-of origin and ten control individuals (10 ml) (Supplementary Table S4 and Fig. 5).
LCR22-2 and LCR22-4 tandem sequence blocks. Slide preparation. Chromatin fibers were obtained 
according to a previously described protocol58. Lymphocytes were isolated from peripheral blood samples in 1% 
sodium heparin by Ficoll-PaqueTM gradient separation. The lymphocyte phase was centrifuged and the pellet was 
washed in 1x PBS. The lymphocyte pellet was resuspended in 1x PBS to reach a final concentration of 2.106 cells/ml. 
10 μ l of the lymphocyte isolation was spread and dried on slides. Slides were placed in Shandon Sequenza 
Coverplates and chromatin fibers were stretched by applying a lysis solution (0.07 M NaOH in ethanol). Fibers 
were fixed in methanol and stored at − 20 °C until they were processed.
DNA probe preparation. BAC and fosmid clones were provided by BACPAC Resources Center, CHORI, USA 
(http://bacpac.chori.org/) and Source BioScience (Supplementary Table S1). We validated probe positioning and 
efficiency using FISH on metaphase chromosomes (see Methods, 22q11.2 inversions).
FISH probes were purified from BACs and fosmid clones using the QIAprep Spin Miniprep Kit (QIAGEN) 
and differentially labelled with Spectrum Orange-dUTP (Abbot Molecular) or digoxigenin-11-dUTP (Roche) by 
Nick Translation (Abbot Molecular). Multiple colour combinations of two delimiting BAC clones and one fosmid 
were simultaneously hybridized on DNA fiber slides. The proximal BAC was labelled with both Spectrum Orange 
and digoxigenin-FITC, the fosmid with digoxigenin-FITC and the distal BAC with Spectrum Orange (Fig. 1B).
After the NICK translation reaction, probes were ethanol precipitated with 1 μ g/ml salmon testis DNA 
(GE Healthcare) and 3 M sodium acetate (pH 5.5) at − 80 °C for 3 h. Probes were purified by centrifugation at 
14,000 rpm for 30 minutes, followed by a wash in 70% ethanol and centrifugation at 14,000 rpm for 6 minutes. The 
probe pellet was air-dried, resuspended in 1x TE buffer (10 mM Tris, 1 mM EDTA, pH 7.0) at a concentration of 
20 ng/μ l and stored at − 20 °C.
FISH on extended chromatin fibers (Fiber-FISH). Probe combinations were prepared by mixing 400 ng of each 
labelled DNA probe with 8 μ g of Cot1 competitor DNA (Invitrogen) per probe. The probe hybridization mixture 
was dried on a heating block at 42 °C and the pellet was resuspended in 10 μ l of LSI/WCP Hybridization Buffer 
(Abbot Molecular). Before hybridization, probes were denatured at 75 °C for 5 minutes and pre-annealed at 37 °C 
for 45 minutes.
Slides were dehydrated in an ethanol series (70, 90 and 100% for 2 minutes each) and dried at room temper-
ature. Chromatin fibers were denatured in 70% formamide/2x SSC at 70 °C for 2 minutes, washed in 2x SSC for 
5 minutes and dehydrated in an ethanol series (70, 85 and 100% for 1 minute each). Probes were applied to slides 
and hybridized in a moist chamber at 37 °C for 48 hours.
Post-hybridization washes were performed in 2x SSC at 42 °C for 3 minutes, followed by 1x PBS at room 
temperature for 5 minutes. Slides were incubated in a blocking solution (5% dried non-fat milk in 1x PBS/0.05% 
Tween-20 (Sigma-Aldrich)) at 37 °C for 30 minutes. Then slides were transferred to 1x PBS at room tempera-
ture for 5 minutes, followed by one hour incubation at 37 °C in detection solution (1% dried non-fat milk in 1x 
PBS/0.05% Tween-20 (Sigma-Aldrich) with 1 μ g/ml fluorescein-conjugated antidigoxigenin (Roche)). Finally, 
Figure 5. Experimental design. 
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slides were washed three times in 1x PBS for one minute, dried out at room temperature and counterstained with 
4’,6-diamidino-2-phenylindole (DAPI, Vysis).
Image acquisition and data analyses. A minimum of 20 informative fibers were scored for every single 
probe combination on an Olympus BX60 epifluorescence microscope equipped with Isis Imaging System 
(Metasystems). Fiber-FISH analyses were developed by applying the following assessment criteria adapted from 
Molina et al.50: (i) at least three signals of different colour combinations must be observed in a consecutive and 
linear fashion, ii) two or more signals of the same colour are considered independent when they are separated by a 
distance twice the distance of every single bead-on-string, and iii) signals are considered informative regardless of 
the size (Fig. 1D). For each BAC and fosmid combination, we scored the frequency of the fosmid signal numbers 
that corresponded to the tandem sequence blocks.
LCR22 paralogous sequences. ddPCR was performed using genomic DNA isolated from peripheral 
blood samples in EDTA. To achieve an optimal fragmentation of LCR22 tandem sequences, 2 μ g of genomic 
DNA was digested with 20U of HaeIII (New England Biolabs) in a final volume of 25 μ l containing 1x NEB4 
buffer for 1 h at 37 °C. The digest was diluted to a final concentration of 6 ng/μ l and 9 ng were assayed per 20 μ l 
ddPCR reaction. Primers and probes were designed for L9 and K3 fosmid clones (reported abnormal CNVs 
of tandem sequence blocks in DGS/VCFS fathers-of-origin). L9 fosmid sequences were assayed using for-
ward primer CAGTGGGACTCTCATCAAAC, reverse primer AGGAGCGAGAAATAGAGTCC and probe 
FAM-AAAGTTGCCATCAGCCAGATGCCAG-Iowa Black® FQ. The 116 bp amplicon corresponded to 
AK129567 gene. K3 fosmid sequences were assayed using forward primer ATTTTGCGGTGTCAGAAGGT, 
reverse primer CCTCTCAGTGACTGTCTCCT and probe FAM-CGGGAGGCAAGCAGTCCCTGGTCC-Iowa 
Black® FQ. The 92 bp amplicon corresponded to AK302545 gene. Both assays were duplexed with an EIF2C1 
reference assay probe labelled with HEX/Iowa Black® FQ (PrimePCR™ ddPCR™ Copy Number Assay EIF2C1, 
Bio-Rad). Amplification conditions were 95 °C for 10 min (1 cycle), 94 °C for 30 s and 55.5 °C × 60 s (40 cycles), 
98 °C × 10 min (1 cycle), and 4 °C hold. Each assay was performed in two replicate ddPCR wells. After PCR, the 
96-well PCR plate was loaded on the droplet reader (Bio-Rad). Positive and negative droplet counts were analysed 
combining data from both replicates and using QuantaSoft analysis software (Bio-Rad). For each replicate, we 
obtained an average number of the amplified copies from two haplotypes.
22q11.2 inversions. Slide preparation. Lymphocytes from peripheral blood samples (collected in 1% 
sodium heparin) were cultured in phytohaemagglutinin-stimulated medium at 37 °C in a 5% CO2 atmosphere 
for 72 h. Cells were treated with colcemid, swelled after a hypotonic treatment (75 mM KCl) and fixed with 3:1 
methanol-acetic acid.
DNA probe preparation. A customized combination of BAC clones RP11-66F9 (abbr. F9), RP11-505B16 
(abbr. B16) and RP11-47L18 (abbr. L18) was used. Probes were labelled with Aqua-dUTPs (Abbott Molecular), 
Spectrum Green-dUTPs (Abbott Molecular) and Spectrum Orange-dUTPs (Abbott Molecular), respectively, as 
described previously for the fiber-FISH assays.
Probe combinations were prepared by mixing 200 ng of each labelled DNA probe with 4 μ g of Cot1 competitor 
DNA (Invitrogen) per probe. The probe hybridization mixture was dried on a heating block at 42 °C and the pellet 
was resuspended in 5 μ l of LSI/WCP Hybridization Buffer (Abbot Molecular).
Interphase FISH. Slides were washed twice in 2x SSC for 3 minutes, dehydrated in an ethanol series (70, 90 and 
100% for 2 minutes each) and dried at room temperature. Slides were denatured in 70% formamide/2x SSC at 
73 °C for 2 minutes, and dehydrated in an ethanol series (70, 85 and 100% for 1 minute each). Probes were applied 
to slides and hybridized in a moist chamber at 37 °C for 24 hours. Post-hybridization washes were performed in 
1x SSC with 0.3% NP-40 at 73 °C and in 2x SSC with 0.1% NP-40 at room temperature for one minute in each 
solution.
Image acquisition and data analyses. Analyses were performed using an Olympus BX60 epifluorescence micro-
scope equipped with an Isis Imaging System (Metasystems). Only those signal combinations with a clear dis-
tribution of two clustered signals (in close proximity or overlapping) and one separated signal were considered 
informative. The distant signal must be separated from the two others by at least a two-fold longer distance com-
pared with the separation of the clustered signals. This probe configuration allowed us to distinguish the normal 
haplotype (N) and the 3 Mb inversion haplotype (inv) (Fig. 1C and E). A minimum of 100 informative signal 
combinations were analysed per sample. Metaphase chromosomes were also observed to test probe specificity.
PRDM9 genotype. The PRDM9 zinc finger array was amplified by PCR in genomic DNA isolated 
from peripheral blood samples in EDTA. PCR was performed using PN0.6 F and PN2.5 R primers (PN0.6 F: 
TGAGGTTACCTAGTCTGGCA, PN2.5 R: ATAAGGGGTCAGCAGACTTC)33, 3% DMSO and BioTaq (Bioline). 
Amplifications were performed as follows: 95 °C for 3 min; 45 cycles of 95 °C for 30 s, 62 °C for 30 s and 72 °C for 
105 s. PCR products were purified with PCR DNA purification kit (Thermo Scientific) and subjected to bidi-
rectional Sanger sequencing with the primers PN1.2 F and PN2.4 R (PN1.2 F: TGAATCCAGGGAACACAGGC 
and PN2.4 R: GCAAGTGTGTGGTGACCACA)33 using BigDye Terminator v3.1 Cycle Sequencing (Applied 
Biosystems) on a ABI 3130XL Genetic Analyzer (Applied Biosystems).
In order to determine which PRDM9 alleles presented each subject, the zinc finger array sequences were 
aligned and compared to published data31,33,46,59.
www.nature.com/scientificreports/
1 0Scientific RepoRts | 7:40031 | DOI: 10.1038/srep40031
Statistical analysis. Data were statistically analysed using Graph Pad Prism 5.03. The statistical significance 
of the results was determined by a p-value less than 0.05.
Data from ddPCR replicates were averaged. To assess CNVs between LCR22 paralogous sequences from 
controls and DGS/VCFS fathers-of-origin, the mean copy number of each fosmid was compared between both 
populations using a Mann-Whitney test. In order to determine whether fiber-FISH and ddPCR technics were 
equivalent, the sum of the fosmid blocks of LCR22-2 and LCR22-4 per individual and the total copy number of 
LCR22 paralogous sequences were compared with a Spearman correlation test.
In the 22q11.2 inversion analyses, differences between haplotype frequencies from control and DGS/VCFS 
parent-of-origin populations were analysed by applying a Mann-Whitney test.
To ascertain the relevance of PRDM9 alleles in the risk for DGS/VCFS, the frequency of each allele was com-
pared between controls and DGS/VCFS parents-of-origin with a Fisher exact test.
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